chr14-73276659-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001005743.2(NUMB):āc.1875T>Cā(p.Asn625=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00506 in 1,614,052 control chromosomes in the GnomAD database, including 124 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.015 ( 39 hom., cov: 32)
Exomes š: 0.0040 ( 85 hom. )
Consequence
NUMB
NM_001005743.2 synonymous
NM_001005743.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 3.12
Genes affected
NUMB (HGNC:8060): (NUMB endocytic adaptor protein) The protein encoded by this gene plays a role in the determination of cell fates during development. The encoded protein, whose degradation is induced in a proteasome-dependent manner by MDM2, is a membrane-bound protein that has been shown to associate with EPS15, LNX1, and NOTCH1. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.55).
BP6
Variant 14-73276659-A-G is Benign according to our data. Variant chr14-73276659-A-G is described in ClinVar as [Benign]. Clinvar id is 769401.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=3.12 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0149 (2269/152168) while in subpopulation AFR AF= 0.039 (1618/41530). AF 95% confidence interval is 0.0374. There are 39 homozygotes in gnomad4. There are 1083 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 2269 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NUMB | NM_001005743.2 | c.1875T>C | p.Asn625= | synonymous_variant | 13/13 | ENST00000555238.6 | NP_001005743.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NUMB | ENST00000555238.6 | c.1875T>C | p.Asn625= | synonymous_variant | 13/13 | 1 | NM_001005743.2 | ENSP00000451300 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0149 AC: 2265AN: 152050Hom.: 39 Cov.: 32
GnomAD3 genomes
AF:
AC:
2265
AN:
152050
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00689 AC: 1734AN: 251490Hom.: 26 AF XY: 0.00584 AC XY: 794AN XY: 135922
GnomAD3 exomes
AF:
AC:
1734
AN:
251490
Hom.:
AF XY:
AC XY:
794
AN XY:
135922
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00403 AC: 5896AN: 1461884Hom.: 85 Cov.: 31 AF XY: 0.00393 AC XY: 2858AN XY: 727240
GnomAD4 exome
AF:
AC:
5896
AN:
1461884
Hom.:
Cov.:
31
AF XY:
AC XY:
2858
AN XY:
727240
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0149 AC: 2269AN: 152168Hom.: 39 Cov.: 32 AF XY: 0.0146 AC XY: 1083AN XY: 74400
GnomAD4 genome
AF:
AC:
2269
AN:
152168
Hom.:
Cov.:
32
AF XY:
AC XY:
1083
AN XY:
74400
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 25, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at